Jagsonpal Pharmaceuticals Limited (BOM:507789)

Market Cap	14.02B
Revenue (ttm)	2.83B
Net Income (ttm)	619.42M
Shares Out	n/a
EPS (ttm)	9.18
PE Ratio	22.64
Forward PE	n/a
Dividend	2.50 (1.19%)
Ex-Dividend Date	Sep 12, 2025

Volume	1,206
Average Volume	4,148
Open	213.95
Previous Close	209.90
Day's Range	209.35 - 213.95
52-Week Range	194.00 - 328.02
Beta	n/a
RSI	39.10
Earnings Date	Oct 27, 2025

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1978
• Employees: 1,399
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507789

Financial Performance

In 2024, Jagsonpal Pharmaceuticals's revenue was 2.69 billion, an increase of 28.76% compared to the previous year's 2.09 billion. Earnings were 553.61 million, an increase of 146.45%.